Comparative Pharmacokinetics and Safety of Imrecoxib, a Novel Selective Cyclooxygenase-2 Inhibitor, in Elderly Healthy Subjects

Yang L, Shen Q, Hu C, Wang Y, Zhu X, Shu S, Luo Z

Drug Design, Development and Therapy 2022, 16:3865-3876

Published Date: 8 November 2022